Related references
Note: Only part of the references are listed.Impact of Community-Based Mass Testing and Treatment on Malaria Infection Prevalence in a High-Transmission Area of Western Kenya: A Cluster Randomized Controlled Trial
Aaron M. Samuels et al.
CLINICAL INFECTIOUS DISEASES (2021)
Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum malaria and prevalence of molecular markers associated with artemisinin and partner drug resistance in Uganda
Chris Ebong et al.
MALARIA JOURNAL (2021)
Association of Plasmodium falciparum kelch13 R561H genotypes with delayed parasite clearance in Rwanda: an open-label, single-arm, multicentre, therapeutic efficacy study
Aline Uwimana et al.
LANCET INFECTIOUS DISEASES (2021)
Evidence of Artemisinin-Resistant Malaria in Africa
Betty Balikagala et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Molecular epidemiology of resistance to antimalarial drugs in the Greater Mekong subregion: an observational study
Mallika Imwong et al.
LANCET INFECTIOUS DISEASES (2020)
Assessment of molecular markers of anti-malarial drug resistance among children participating in a therapeutic efficacy study in western Kenya
Winnie Chebore et al.
MALARIA JOURNAL (2020)
African isolates show a high proportion of multiple copies of the Plasmodium falciparum plasmepsin-2 gene, a piperaquine resistance marker
Didier Leroy et al.
MALARIA JOURNAL (2019)
Evolution and expansion of multidrug-resistant malaria in southeast Asia: a genomic epidemiology study
William L. Hamilton et al.
LANCET INFECTIOUS DISEASES (2019)
Are k13 and plasmepsin II genes, involved in Plasmodium falciparum resistance to artemisinin derivatives and piperaquine in Southeast Asia, reliable to monitor resistance surveillance in Africa?
Francis Foguim Tsombeng et al.
MALARIA JOURNAL (2019)
Absence of kelch13 artemisinin resistance markers but strong selection for lumefantrine-tolerance molecular markers following 18 years of artemisinin-based combination therapy use in Mpumalanga Province, South Africa (2001-2018)
Jaishree Raman et al.
MALARIA JOURNAL (2019)
Comparative Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Malaria in Ugandan Children
Adoke Yeka et al.
JOURNAL OF INFECTIOUS DISEASES (2019)
Plasmodium falciparum Plasmepsin 2 Duplications, West Africa
Juliana Inoue et al.
EMERGING INFECTIOUS DISEASES (2018)
A surrogate marker of piperaquine-resistant Plasmodium falciparum malaria: a phenotype-genotype association study
Benoit Witkowski et al.
LANCET INFECTIOUS DISEASES (2017)
Capacity Development through the US President's Malaria Initiative-Supported Antimalarial Resistance Monitoring in Africa Network
Eric S. Halsey et al.
EMERGING INFECTIOUS DISEASES (2017)
The effect of malaria control on Plasmodium falciparum in Africa between 2000 and 2015
S. Bhatt et al.
NATURE (2015)
Efficacy and safety of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated Plasmodium falciparum malaria in Kenyan children aged less than five years: results of an open-label, randomized, single-centre study
Bernhards R. Ogutu et al.
MALARIA JOURNAL (2014)
The Origins of Antimalarial-Drug Resistance
Randall M. Packard
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Spread of Artemisinin Resistance in Plasmodium falciparum Malaria
E. A. Ashley et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Dihydroartemisinin-Piperaquine vs. Artemether-Lumefantrine for First-Line Treatment of Uncomplicated Malaria in African Children: A Cost-Effectiveness Analysis
Johannes Pfeil et al.
PLOS ONE (2014)
Malaria Transmission After Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine: A Randomized Trial
Patrick Sawa et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
A randomized trial of artemether-lumefantrine and dihydroartemisinin-piperaquine in the treatment of uncomplicated malaria among children in western Kenya
Aarti Agarwal et al.
MALARIA JOURNAL (2013)
Development of standardized laboratory methods and quality processes for a phase III study of the RTS, S/AS01 candidate malaria vaccine
Christine Swysen et al.
MALARIA JOURNAL (2011)
Evaluation of Recurrent Parasitemia after Artemether-Lumefantrine Treatment for Uncomplicated Malaria in Children in Western Kenya
Joseph V. Woodring et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2010)
Artemisinin Resistance in Plasmodium falciparum Malaria.
Arjen M. Dondorp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya
Petra F. Mens et al.
MALARIA JOURNAL (2008)
Evidence of Artemisinin-Resistant Malaria in Western Cambodia
Harald Noedl et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Artemether-Lumefantrine versus Dihydroartemisinin-Piperaquine for Treating Uncomplicated Malaria: A Randomized Trial to Guide Policy in Uganda
Adoke Yeka et al.
PLOS ONE (2008)
Adherence and efficacy of supervised versus non-supervised treatment with artemether/lumefantrine for the treatment of uncomplicated Plasmodium falciparum malaria in Bangladesh:: a randomised controlled trial
Md. Mushfiqur Rahman et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2008)
The evolution of drug-resistant malaria
Christopher V. Plowe
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2008)
The challenges of changing national malaria drug policy to artemisinin-based combinations in Kenya
Abdinasir A. Amin et al.
MALARIA JOURNAL (2007)
Use of refractometry and colorimetry as field methods to rapidly assess antimalarial drug quality
Michael D. Green et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2007)
Molecular and pharmacological determinants of the therapeutic response to artemether-lumefantrine in multidrug-resistant Plasmodium falciparum malaria
RN Price et al.
CLINICAL INFECTIOUS DISEASES (2006)
Antimalarial drug resistance, artemisinin-based combination therapy, and the contribution of modeling to elucidating policy choices
S Yeung et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2004)
Pharmacokinetics and pharmacodynamics of lumefantrine (benflumetol) in acute falciparum malaria
F Ezzet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2000)
Share Paper
